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BiomaterialsNo treatments exist to effectively treat many retinal diseases. Retinal pigmented epithelium (RPE) and
neural retina can be generated from human embryonic stem cells/induced pluripotent stem cells
(hESCs/hiPSCs). The efficacy of current protocols is, however, limited. It was hypothesised that generation
of laminated neural retina and/or RPE from hiPSCs/hESCs could be enhanced by three dimensional (3D)
culture in hydrogels. hiPSC- and hESC-derived embryoid bodies (EBs) were encapsulated in 0.5% RGD-
alginate; 1% RGD-alginate; hyaluronic acid (HA) or HA/gelatin hydrogels and maintained until day 45.
Compared with controls (no gel), 0.5% RGD-alginate increased: the percentage of EBs with pigmented
RPE foci; the percentage EBs with optic vesicles (OVs) and pigmented RPE simultaneously; the area cov-
ered by RPE; frequency of RPE cells (CRALBP+); expression of RPE markers (TYR and RPE65) and the retinal
ganglion cell marker, MATH5. Furthermore, 0.5% RGD-alginate hydrogel encapsulation did not adversely
affect the expression of other neural retina markers (PROX1, CRX, RCVRN, AP2a or VSX2) as determined by
qRT-PCR, or the percentage of VSX2 positive cells as determined by flow cytometry. 1% RGD-alginate
increased the percentage of EBs with OVs and/or RPE, but did not significantly influence any other mea-
sures of retinal differentiation. HA-based hydrogels had no significant effect on retinal tissue develop-
ment. The results indicated that derivation of retinal tissue from hESCs/hiPSCs can be enhanced by
culture in 0.5% RGD-alginate hydrogel. This RGD-alginate scaffold may be useful for derivation, transport
and transplantation of neural retina and RPE, and may also enhance formation of other pigmented, neural
or epithelial tissue.
Statement of Significance
The burden of retinal disease is ever growing with the increasing age of the world-wide population.
Transplantation of retinal tissue derived from human pluripotent stem cells (PSCs) is considered a
promising treatment. However, derivation of retinal tissue from PSCs using defined media is a lengthy
process and often variable between different cell lines.
This study indicated that alginate hydrogels enhanced retinal tissue development from PSCs, whereas
hyaluronic acid-based hydrogels did not. This is the first study to show that 3D culture with a biomaterial
scaffold can improve retinal tissue derivation from PSCs.
These findings indicate potential for the clinical application of alginate hydrogels for the derivation and
subsequent transplantation retinal tissue. This work may also have implications for the derivation of
other pigmented, neural or epithelial tissue.
Crown Copyright  2016 Published by Elsevier Ltd on behalf of Acta Materialia Inc. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In 2010, it was estimated that globally 32.4 million people were
classified blind, and 191 million were visually impaired [1].
Diseases affecting the retina account for approximately 26% of
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of retinal disease is ever growing with the increasing age of the
world-wide population [3,4]. Both neural retina and the supportive
retinal pigmented epithelium (RPE) fail to regenerate in humans,
therefore diseases that cause retinal cell loss, such as age-related
macular degeneration (AMD), retinitis pigmentosa (RP) and other
hereditary retinal dystrophies including glaucoma and vascular
retinopathies, typically result in permanent visual impairment [5].
The transplantation of retinal tissue and other cell types has
been explored to treat retinal disease. A clinical trial involving 10
patients either with AMD or RP showed that visual acuity was
improved in 70% of patients by the transplantation of human foetal
neural retina together with RPE into the subretinal space, without
the use of immunosuppression [6]. Conversely, the transplantation
of adult retinal cells has proved unsuccessful [7,8]. There is, how-
ever, limited availability of foetal tissue for transplantation, and
the ethical issues associated with this approachmean that it is unli-
kely to be a feasible treatment option for a large number of patients.
In 2007, itwas shown that human induced pluripotent stem cells
(hiPSCs) can be generated from patients’ dermal fibroblasts [9].
hiPSCs, like embryonic stem cells (hESCs) can be differentiated into
both laminated neural retina and RPE [10–14]. Transplantation of
retinal cells derived from hESCs and hiPSCs is considered to be a
promising treatment for patients with macular degeneration and
inherited retinal disease. Shirai et al. [15] were able to show that
hESC can be coaxed to differentiate to laminated retinaewhich upon
transplantation into the subretinal space of rat and primate models
of retinal degeneration differentiated into a range of retinal cell
types, developed a well-organised outer and inner nuclear layer
and formed synaptic connectionswith the host retina. Patients with
advanced retinal degeneration may require transplantation of RPE,
photoreceptors, and/or other retinal cells, hence the generation of
hESC/hiPSC-derived laminated retina presents a significant step
towards the design of human clinical trials. To be able to achieve
this, safe, robust and efficient differentiation methods that comply
with good-manufacturing practice need to be devised. Preliminary
results from stage I/II clinical trials have shown that RPE cells gener-
ated from hESCs can successfully be transplanted [16] into the sub-
retinal space without causing adverse events in patients with AMD
or Stargardt’s disease, however clinical trials on transplantation of
neural retinal sheets from hESC or hiPSC have not yet been per-
formed. This is due in part to the length of current differentiation
protocols (up to 250 days) [17].
Generation of retinal tissue is useful not only for transplanta-
tion purposes but also for the study of retinal diseases in vitro.
The normal retina consists of multiple layers of neural tissue,
which are in direct contact with and supported by the RPE. Both
tissues are required for visual function. Several retinal diseases
affect the neural retina and the RPE, yet the way in which each
of these tissue types are affected, is not well understood [18].
Therefore the development of suitable protocols which result in
the generation of neural retina in conjunction with RPE may be
useful for studying retinal disease [19].
It is increasingly being recognised that the extracellular matrix
(ECM) is important for the correct development and function of
the retina both in vivo and in vitro [20–25], and changes in the
ECM are associated with age-related degenerative changes in the
retina including AMD [26]. Mutations affecting several components
of the retinal ECM have been identified in patients with retinal dis-
ease [27–33]. Several animal models have also demonstrated how
mutations in other ECM components can affect retinal ontogenesis
and are associated with age-related degenerative changes [34–38].
It was hypothesised that recreation of the retinal microenviron-
ment during hESC and hiPSC differentiationmay provide the critical
micro-environmental cues that are needed for their efficient differ-
entiation to fully laminated neural retina with RPE.The retinal ECM and Bruch’s membrane (BrM), are enriched in
proteoglycans [39,40]. A number of studies have shown that the
major component of the retina is hyaluronic acid (HA), a large
non-sulphated polysaccharide which binds a number of secreted
proteins including other ECMs, such as link proteins and proteogly-
cans [24,40–42]. Recent work has suggested that HA-based hydro-
gels can drive neural [43] and retinal differentiation under 3D
conditions and can also be used to deliver cells into the retina
[44–48] as well as other areas of the CNS [49,50]. Similarly, RGD-
alginate hydrogels appear to be promising scaffolds and have been
successfully used to transplant primary foetal retinal tissue in rats
[51] and to promote neural differentiation of mouse ESCs [52].
Alginate has been shown to maintain good viability of encapsu-
lated primary and adult human RPE cell lines [53,54]. Furthermore,
encapsulation in 1% alginate hydrogels has been shown to enhance
the pigmented RPE phenotype of both human and porcine primary
adult RPE and the expression of typical RPE markers such as RPE65
and tyrosinase [53,55]. Additionally, both alginate and HA are used
in ophthalmic products, including those used intraocularly [56,57],
and are well tolerated in the eye.
The addition of insulin-like growth factor 1 (IGF-1) to serum-
free media has previously been shown to enhance formation of
hESC-derived 3D laminated neural retina containing functional
photoreceptors with membrane capabilities amenable to photo-
transduction [13]. Here it was investigated whether the 3D culture
of hESC- and hiPSC-derived tissue, in the same defined media with
IGF-1, within HA, HA/gelatin, 0.5% RGD-alginate or 1% RGD-alginate
could enhance retinal differentiation compared with suspension
culture in media alone. The resulting effects of hydrogel encapsula-
tion on both RPE and neural retina formation were assessed.2. Methods and Materials
Unless otherwise specified, all reagents were purchased from
Sigma Aldrich (Dorset, UK).2.1. Cell culture and generation of embryoid bodies (EBs)
The experimental procedure is summarised in Fig. 1. The H9
hESC line (Wicell Inc.) and SB-AD3 hiPSC line (derived and fully
characterised) were cultured on growth factor reduced Matrigel-
coated 6-well plates in mTeSR1 media (Stem Cell Technologies,
Cambridge, UK) supplemented with penicillin-streptomycin (P/S,
1% v/v). EBs were generated by dissociating cells at 90% confluence
with Accutase (Thermo Fisher Scientific) and seeding 9000 cells
into each well of a 96-well lipidure-coated U-bottom plate (Ams-
bio, MA, USA) in 100 ll of mTeSR1 with 10 lM ROCK inhibitor
(Y27632, Tocris, Bristol, UK). On day 3, media was changed to dif-
ferentiation media (DMEM/F12 with 1% P/S, Thermo Fisher Scien-
tific 20% KOSR (Thermo Fisher Scientific, Glasgow, UK), IGF-1
(5 ng/ml, R and D systems, Minneapolis, USA) and B27, Thermo
Fisher Scientific). Media was changed every 3 days thereafter, with
serum reduced to 15% at day 5, then 10% at day 9, before finally
culturing the cells in serum-free media from day 37 onwards, sup-
plemented with 1% P/S, 10 ng/ml IGF-1,B27 and N2 (Thermo Fisher
Scientific, Glasgow, UK). EBs were maintained in 96-well plates
until day 12 when they were transferred to ultra-low-attachment
plates (Corning) and either kept suspension in media (controls)
or encapsulated in hydrogel (0.5% RGD-alginate, 1% RGD-alginate,
HA or HA/gelatin – as specified below) and cultured until day 45.
Control EBs were then cultured in 3D suspension in media only
throughout the duration of the experiment (45 days) as previously
described [13]. Scans, photos and samples of EBs were taken at day
30 and 45 for analysis via immunohistochemistry (IHC), qRT-PCR
and flow cytometry.
Fig. 1. a) Schematic showing the different protocols followed. hESC/hiPSC were cultured on Matrigel in mTeSR1 media, then embryoid bodies (EBs) were generated using
ultra low adhesion U-shaped 96-well plates. EBs were maintained in 96-well plates until day 12 when they were transferred to petri-dishes or low attachment 6 well plates
and either kept in suspension in media (controls) or encapsulated in hydrogel (0.5%/ 1% RGD-alginate, HA HA/ gelatin hydrogels) and cultured until day 45. Over time the
development of phase bright tissue at the edge of EBs reminiscent of the evaginating optic vesicle (OV) were observed along with pigmented RPE foci as indicated in the ‘OV
+ RPE’ image. Scans, photos and samples of EBs were taken at 30 and 45 days. Samples were analysed via IHC, qRT-PCR and flow cytometry (full details can be seen in the
Methods section), scale bar 100 lm for the left hand side panel and 500 lm for the middle and right hand panel. b) Schematic showing the progression of normal human
retinal differentiation and lamination together with characteristic markers of different retinal cell types. Laminated adult human neural retina and retinal pigmented
epithelium (RPE) arise from common eye field progenitor cells. These cells either go on to express MITF1 and further differentiate into RPE cells, or VSX2-positive retinal
progenitor cells (RPCs) before differentiating into neural retinal cell types which include photoreceptors, bipolar cells, amacrine cells, Müller cells, horizontal cells and retinal
ganglion cells. The expression of key phenotypic markers is indicated. These markers were used to identify retinal cells in cultures at day 30 and day 45 of differentiation.
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Gly-Arg-Gly-Asp-Ser-Pro- (GRGDSP-) coupled high guluronic
acid, high molecular weight alginate (NOVATACH MVG GRGDSP,
Novamatrix, PA, USA) (RGD-alginate) was prepared to either 0.5%
or 1% w/v concentration by the addition of differentiation media
containing 10% w/v KOSR. 12-day old EBs were mixed with the
RGD-alginate solutions, which were crosslinked by immersion in
0.1 M calcium chloride for two hours, as previously described [58].
HystemTM (thiolated-HA) (referred to as ‘HA’ form hereon in) and
Hystem-CTM (1:1 thiolated HA: thiolated-gelatin) (referred to as
‘HA/gelatin’ from hereon in) were prepared according to the manu-facturer’s instructions, which involved addition of the thiol reactive,
ExtralinkTM, crosslinking agent followed by incubation at 37 C for
approximately 30 min, until fully polymerised. Acellular hydrogels
for rheological and Scanning Electron Microscopy (SEM) analysis
were made the same way, without the addition of EBs.
2.3. Morphological characterisation of hydrogels via scanning electron
microscopy (SEM)
RGD-alginate and HA-based gels were prepared according to
the method described above. Samples were immediately fixed in
2% glutaraldehyde in HEPES buffered saline for one hour, then
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dried (Labconco, Freezone 1) with an ice condenser temperature of
55 C for 24 h, until all the solvent sublimed. Each sample was
then mounted on a carbon disk supported by an aluminium stub
and coated with a 15 nm layer of gold (Polaron SEM, Coating Unit).
Representative images of the hydrogel morphology were collected
by SEM (Cambridge Stereoscan 240). Maximum pore diameters in
SEM images of hydrogels were determined using Image J (National
Institute of Health (NIH), Maryland, USA). Images were converted
to 8-bit, pores were traced using the wand tool, filled, then after
thresholding to show only the filled pores, the size of these regions
was analysed using the analyse particles function. For all hydro-
gels, P120 pores were analysed. It should be noted that the met-
rics presented are for dry scaffolds and while they are correlated
to the hydrated scaffold they are not descriptive of its properties.2.4. Mechanical characterisation of hydrogels via rheology
Rheological characterisation of hydrogels was performed using
Malvern Kinexus Pro+ rotational rheometer (Worcestershire, UK)
which is equipped with a temperature control stage. Samples of
20 mm in diameter with planar surfaces were cast in stainless steel
moulds, as described above. 20 mm diameter serrated parallel
plates were used to avoid slippage. The thickness of samples was
2.3–2.5 mm. The plate gap was set to be identical to the sample
thickness. A special solvent trap system was used to avoid dehy-
dration of the sample. To identify the linear viscoelastic region
(LVR), oscillatory strain sweep tests were applied between 0.01%
and 10%. Frequency sweep tests were then performed between
0.1 Hz and 10 Hz at 0.1% which was within the LVR. The storage
(elastic component) modulus (G0), loss (viscous component) mod-
ulus (G00) and dynamic viscosity (g⁄) were extracted to assess the
mechanical spectra of the gels at 37 C. Detailed comparisons of
G0, G00 and g⁄ were made between gels at a frequency of 1 Hz.2.5. Quantitative assessment of retinal determination in 3D culture
For each experimental condition, the total number of EBs with
phase bright OVs as described in a recent publication [13], and/or
any pigmented RPE foci were counted under a dissection micro-
scope on days 30 and 45 of differentiation. 134 ± 7 EBs were
counted for each sample. This analysis was repeated by a second
experienced person to ensure an objective evaluation across all
culture conditions.2.6. RNA extraction, RT and qRT-PCR
20–50 EBs were homogenised using a pestle and mortar and
RNA was extracted using a tissue extraction kit (Promega, USA) as
per the manufactures instructions. 1 lg of RNA was reverse tran-
scribed using random primers (Promega, USA). qRT-PCR was per-
formed using a Quant Studio 7 Flex system (Applied Biosystems,
USA) with SYBR Green (Promega, USA). Each primer (listed in
Table 1) was used at a concentration of 1 lM, and at a ratio of
50:50 for forward and reverse. The reaction parameters were as
follows: 95 C for 15 min to denature the cDNA and primers, 40
cycles of 94 C for 15 s followed by primer specific annealing tem-
perature for 30 s, succeeded by a melt curve. A comparative Ct
method was used to calculate the levels of relative expression,
whereby the Ct was normalised to the endogenous control
(GAPDH). This calculation gives the DCt value, which was then nor-
malised to a reference sample (i.e. a positive control), giving the
DDCt. The fold change was calculated using the following formula:
2-DDCt.2.7. Flow cytometry
EBs were dissociated in a 1:1 mix of AccumaxTM (Merk Millipore,
Hertfordshire, UK) and TrypLETM (Thermo Fisher Scientific, Glasgow,
UK) at 37 C for 60 min, with agitation every 10 minutes. Cells
were collected and fixed in 4% paraformaldehyde (PFA) in PBS at
37 C for 10 minutes then washed in PBS and stored in 90% metha-
nol in PBS at -20 C before analysis. Cells were blocked in PBS con-
taining 2% bovine serum albumin (BSA) and 2% normal goat serum
for one hour at room temperature. Primary antibodies were diluted
as stated in Table 2 and incubated with the cells for one hour in PBS
with 0.5% BSA. After two washes in PBS, cells were incubated in
secondary antibodies (AlexafluorTM goat-anti-rabbit 647 and goat-
anti-mouse 488), (Thermo Fisher Scientific, Glasgow, UK), diluted
1/800 in PBS with 0.5% BSA, at room temperature for one hour,
before washing and suspending the cells in PBS with 10% v/v DAPI.
Cells were then analysed via flow cytometry (BD FACSCantoTM, BD
Biosciences, CA, USA).
2.8. Immunohistochemistry (IHC)
EBs were collected on days 30 and 45 of differentiation and IHC
analysis performed on cryostat sections as described previously
[13]. A panel of antibodies listed in Table 2 were used for this anal-
ysis. At least ten EBs were sampled from each differentiation con-
dition on days 30 and 45 for analysis. Images were obtained using a
Zeiss Axio Imager.Z1 microscope with ApoTome.2 accessory equip-
ment and AxioVision software (Zeiss, Oberkochen, Germany).
2.9. Quantification of pigmented RPE foci
The area occupied by pigmented RPE foci were non-
destructively determined similarly to the method previously
described [58]. Dishes containing 3D EB structures were scanned
at day 30 and 45 (Epson Perfection V200) at 600 DPI resolution.
The resulting 2D scans were analysed in ImageJ (NIH, Maryland,
USA). EBs were manually outlined at high magnification so that
the total area occupied by EBs could be determined. Scans were
converted to saturation density using the Colour Transformer plu-
gin. A threshold was then applied so that only pigmented RPE foci
were shown (as indicated in Fig. 6a). The area occupied by pig-
mented RPE foci was measured so that the percentage of the total
number of EBs within the culture which were pigmented could be
determined i.e.% pigmentation = (area of pigmented RPE foci/total
area occupied by EBs)  100. Although RPE and EBs were 3D struc-
tures and not a monolayer, the quantification of % area occupied by
RPE within the EBs from 2D images was assumed to reflect the dif-
ferences in volume occupied by the RPE between samples.
2.10. Statistical analysis and data presentation
All analysis was performed using the open access statistical
software R Project (R Foundation for Statistical Computing, Vienna,
Austria), and significance was set at a p-value < 0.05. In all experi-
ments, statistical significance was determined using generalised
linear models (GLMs). Using GLMs allowed quantification of the
effect size of the various input variables (time in culture, cell type,
hydrogel type) on the response variable (e.g., specific gene expres-
sion) as, for example, is similarly described in a recent paper [59].
The model used was lm (response variable  cell type + hydrogel
condition + time point). A power analysis determined the sample
number sufficient to identify significant differences with 95% con-
fidence and 80% power. All samples were performed in replicates
of three or more, and data presented as mean ± SEM, unless other-
wise stated. Since at least three biological replicates were per-
formed for each cell type, under each experimental condition and
Table 1
DNA oligonucleotides used for qRT-PCR.
Gene Forward primer Reverse primer
GAPDH TGCACCACCAACTGCTTAGC GGCATGGACTGTGGTCATGAG
VSX2 (CHX10) GGCGACACAGGACAATCTTTA TTCCGGCAGCTCCGTTTTC
MITF1 TTCACGAGCGTCCTGTATGCAGAT TTGCAAAGCAGGATCCATCAAGCC
RCVRN TTCAAGGAGTACGTCATCGCC GATGGTCCCGTTACCGTCC
CRX GTGAGGAGGTGGCTCTGAAG CTGCTGTTTCTGCTGCTGTC
RPE65 GCCCAGGAGCAGGACAAAAG GCGCATCTGCAAGTTAAAACCA
TYR TAGCGGATGCCTCTCAAAGC CAATGGGTGCATTGGCTTCT
MATH5 CCCTAAATTTGGGCAAGTGAAGA CAAAGCAACTCACGTGCAATC
PROX1 TGACTTTGAGGTTCCAGAGAGA CTCTTGTAGGCAGTTCGGGG
AP2a GTTACCCTGCTCACATCACTAG TCTTGTCACTTGCTCATTGGG
Table 2
Antibodies used for immunolabelling cells for flow cytometry and immunohistological analysis showing dilutions used.
Protein Supplier Cat. number Dilution (Flow cytometry) Dilution (IHC)
CRALBP Source Bioscience GTX15051 1/100 1/200
VSX2 (CHX10) Sigma Atlas HPA003436 1/100 1/50
Cleaved caspase 3 New England Biolabs 9661S 1/100 1/200
Ki-67 Abcam ab15580 1/100 1/200
RBPMS PhosphoSolutions 1830-RBPMS 1/400 1/200
RCVRN Millipore AB5585 1/100 1/800
HuC/D Invitrogen (Molecular probes) A21271 1/800 1/200
AP2a Santa Cruz Biotechnology sc-184 1/100 1/100
COL-IV Abcam ab6586 1/100 1/250
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were used in each statistical model. Graphs were prepared in Prism
(GraphPad, CA, USA) from the raw data.
3. Results
The effect of hydrogel encapsulation on retinal differentiation of
hESC- and hiPSC-derived EBs under serum-free defined conditions
was assessed using a combination of techniques including qRT-
PCR, IHC and flow cytometry. Four different hydrogels were used
to encapsulate EBs generated from hESCs and hiPSCs; 0.5% RGD-
alginate, 1% RGD-alginate, HA and HA/gelatin (Fig. 1a). The specific
details of these hydrogels are given in the methods section. In pre-
liminary work, normal alginate lacking the RGD motif was also
investigated, but unfortunately culture in this alginate resulted in
a reduction in the percentage of retinal structures and in the
appearance of numerous abnormal cystic structures (data not
shown). Furthermore, in normal alginate, many EBs dissociated,
indicative of reduced cell viability. We therefore used RGD-
alginate in this study, which is widely used in tissue engineering,
and has previously been shown to enhance the viability of mes-
enchymal stem cells.
EBs were encapsulated on day 12 upon transfer from 96-well
dishes into low attachment 6-well plates and the differentiation
of EBs towards a retinal phenotype was assessed at day 30 and
45 (Fig. 1a). The ability of EBs to form 3D laminated neural retina
with retinal pigmented epithelium (RPE) was assessed and com-
pared between the different hydrogels and controls (suspension
culture in media only with no hydrogel). A schematic showing
how native laminated retinal tissue arises from common progeni-
tor cells, with key markers used to identify emergence of the differ-
ent cell types, is shown in Fig. 1b.
3.1. Hydrogel characterisation
A comparison of mechanical and microstructural properties of
hydrogels was made using SEM imaging and rheology and
described in the supplementary section (Suppl. Figs. 1 and 2 and
accompanying text).3.2. Hydrogel encapsulation maintained high cell viability and the
ability of EBs to generate retinal tissue
Over time the development of phase bright tissue at the edge of
EBs reminiscent of the OVs was observed (Fig. 2a), along with pig-
mented RPE foci which, under high power magnification, showed
the typical hexagonal RPE morphology. EBs displaying OVs which
lacked RPE, EBs containing both OVs and pigmented RPE foci, or
EBs lacking OVs but displaying RPE foci alone were observed and
quantified under all five conditions. Examples of EBs displaying
the simultaneous occurrence of OVs with pigmented RPE are
shown for both hESC- and hiPSC- derived cultures under each con-
dition in Fig. 2a. EBs appeared to remain healthy and viable under
all five conditions throughout the course of the experiment upon
visual examination. The number of cells in which expressed the
apoptotic marker cleaved-caspase-3 (CASP-3) was measured by
flow cytometry to assess the level of cell death under each condi-
tion for both hESC and hiPSC-derived EBs at day 45, when the
experiment was terminated (Fig. 2b). Levels of apoptosis were
low in all samples and the number of CASP-3-positive cells was
not significantly different between hydrogel and control samples,
showing that hydrogel encapsulation had no adverse effect on cell
viability (p > 0.05). The low numbers of CASP-3 expressing cells
under all conditions was also confirmed by IHC, and a representa-
tive image is shown in Fig. 2c. Furthermore, EBs were seen to
increase in size throughout the course of the experiment in all
hydrogels as they did in controls, and proliferating cells (express-
ing Ki-67) were frequently observed within developing retinal tis-
sue at both day 30 and day 45. A representative image showing the
IHC staining obtained for Ki-67 is shown in Fig. 2d.
3.3. Occurrence of OVs and pigmented RPE foci is increased by RGD-
alginate hydrogels
To determine whether hydrogel encapsulation affected the
propensity of EBs generated from hESCs and hiPSCs to generate
retinal tissue, was compared between hydrogel conditions and
controls (Fig. 3). As described in the methods, statistical analysis
was performed using a linear model, and therefore all data is
Fig. 2. Encapsulation of EBs in hydrogels does not affect cell viability or adversely impact the emergence of phase bright OVs and RPE. a) Representative examples of EBs
which had developed both OV and pigmented RPE foci from hESCs and hiPSCs at day 45 under control conditions and in 0.5% RGD-alginate, 1% RGD-alginate, HA, HA/ gelatin
hydrogels. Pigmented RPE foci are indicated by white arrows, while OVs under all five conditions are indicated with black arrows (Scale bar = 200 lm). b) Percentage of cells
derived from hESCs and hiPSCs in all five conditions which expressed cleaved caspase-3 (CASP-3) as measured by flow cytometry at day 45, indicating that levels of apoptosis
were low under all conditions and comparable between conditions (p > 0.05). c) Levels of CASP-3 (apoptosis marker) expression in hiPSC- and hESC-derived EBs were
observed by IHC at both day 30 and day 45 and representative image is shown, confirming the low expression seen by flow cytometry in panel b. d) Viability of cells was
further indicated by high numbers of proliferating (Ki-67-positive) cells within EB-derived OVs at days 30 and 45 for all samples. A representative image is shown.
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to be real and repeatable, are identified. In each case the effect of
time in culture, the hydrogel condition (compared with control)and the cell type on the occurrence of retinal structures was deter-
mined, similarly to the qRT-PCR and other quantifications that
follow.
Fig. 3. Effects of hydrogel encapsulation on the hESC/hiPSC retinal differentiation. Quantitative assessment of retinal structures at day 30 and 45 derived from hESCs or hiPSCs
cultured in 0.5% and 1% RGD-alginate, 1%, HA, HA/ gelatin hydrogels compared with 3D suspension culture in media only (control). All values are stated as the % of the total
population of EBs. The percentage of EBswith OVs and/or pigmented RPE foci (total retinal); the % of EBswith pigmented RPE foci (with orwithout OV); the % EBswith OVs (with
orwithout RPE); and % EBswith both pigmented RPE foci andOV together are shown. The percentage of EBswith emergingOVs and RPE foci together, aswell as EBswith RPE foci
(with orwithout OVs)were significantly increased by both 0.5% and 1%RGD-alginates (p < 0.05). 1% RGD-alginate also significantly increased the % of EBswithOVs (p < 0.05). All
measures were significantly increased at day 45 compared with day 30 (p < 0.05) and the percentage of EBs with OVs was increased in hiPSCs compared with hESCs. No other
significant differences were found. This implied that both alginate hydrogels increased retinal differentiation compared with control conditions.
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nal) (Fig. 3) was found to be significantly increased by both 0.5%
and 1% RGD-alginate hydrogels (17% and 15.5% respectively;
p < 0.05) compared to controls (p < 0.05), but was not significantly
affected by the HA and HA/gelatin hydrogels (p > 0.05). This
increase in the total retinal group is evident in both hESC and
hiPSC cultures at both day 30 and day 45, although the magnitude
varied between sub-groups. Furthermore, the percentage of EBs
displaying either RPE and/or OVs was increased at day 45 by an
average of 21% compared with day 30 (p < 0.05). Although the
appearance of retinal structures appeared slightly increased in
hiPSCs compared with hESCs, this increase was not significant
(p > 0.05).
Similarly, the total number of EBs containing pigmented RPE
foci (either with or without OVs) (Fig. 3) was also significantly
increased in 0.5% RGD-alginate by an average of 17% (p < 0.05)and in 1% RGD-alginate by an average of 13.5% (p < 0.05), and unaf-
fected by HA-based hydrogels (p > 0.05). Again, this increase is evi-
dent at both time points for both cell types to different degrees.
The percentage of EBs displaying RPE, was increased by an average
of 20% at day 45 compared with day 30, but not significantly differ-
ent between hESCs or hiPSCs (p > 0.05).
The percentage of EBs with OVs (either with or without simul-
taneous RPE) (Fig. 3) was significantly increased in 1% RGD-
alginate by an average of 14%, (p < 0.05). No significant increases
in total OV numbers were seen in the other hydrogels, including
0.5% RGD-alginate (p > 0.05). Numbers of OVs were increased by
an average of 8.5% at day 45 compared with day 30 (p < 0.05)
and hiPSCs generated on average 10% more OVs than hESCs
(p < 0.05).
The simultaneous appearance of OVs along with pigmented RPE
in the same EB (Fig. 3) was increased by 0.5% RGD-alginate and 1%
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but not significantly affected by the HA or HA/gelatin hydrogels
(p > 0.05). At day 45 the number of EBs with OVs and RPE together
was increased by 7.5% on average, compared with day 30
(p < 0.05). No significant differences in total numbers of OVs were
seen between the hiPSCs or hESCs (p > 0.05). Overall, the quantita-
tive assessment performed over day 30 and 45 of differentiation
suggest that both 0.5% and 1% RGD-alginate can enhance retinal
differentiation of hESCs and hiPSCs.
3.4. 5% RGD-alginate hydrogels enhanced RPE formation in 3D retinae
derived from hESCs and hiPSCs
The results shown in Fig. 3 indicate that both 0.5% and 1% RGD-
alginate could increase the formation of RPE fromhESCs and hiPSCs.
To validate this finding, qRT-PCR analysis was performed on hESC-
and hiPSC-derived retinal tissue on days 30 and 45 of differentia-
tion (Fig. 5) with RPE markers characterising the early (MITF1)
and definitive commitment of retinal progenitor cells to an RPE
phenotype (TYR and RPE65). Interestingly, MITF1 expression
dropped dramatically between day 30 and 45 for hiPSC-derived cul-
tures, but was relatively low at both day 30 and day 45 in hESC cul-
tures (Fig. 5). Overall, the expression ofMITF1was not significantly
different from controls in any of the hydrogels (p > 0.05). RPE65, a
definitive marker of RPE, was found to be significantly increased
in 0.5% RGD-alginate (p < 0.05), when compared with controls
(Fig. 4). Expression of RPE65 was not significantly affected by 1%
RGD-alginate, HA or HA/gelatin hydrogels (p > 0.05). RPE65 expres-
sion was significantly increased at day 45 compared with day 30
(p < 0.05), where expressionwas seen to be up to 4-fold higher than
normal human RPE. RPE65 expression was also significantly higher
in hiPSC- compared with hESC-derived cultures (p < 0.05).
Expression of TYR, another marker of RPE cells and which codes
for one of the proteins essential for pigment synthesis was also
analysed via qRT-PCR (Fig. 4). Expression of TYR, similarly to
RPE65 was significantly increased in 0.5% RGD-alginate samples
compared with controls (p < 0.05), with no significant differences
for any of the other hydrogels, including 1% RGD-alginate
(p < 0.05). Together these qRT-PCR results supported the finding
that 0.5% RGD-alginate enhances RPE formation compared with
controls, as suggested by the quantitative analysis in Fig. 3, and
that HA and HA/gelatin have no significant effect on RPE formation.
However, the qRT-PCR results did not support the finding that 1%
RGD-alginate increased RPE formation reported in the previous
Results section.
To further investigate whether RGD-alginate hydrogels could
enhance RPE formation, analysis of the area occupied by pigment
in scanned images of hESC and hiPSC-derived EBs at day 30 and
45 was assessed (Fig. 5a and b). From the image analysis it was
found that, in agreement with all other data, the formation of
pigmented RPE was not increased by either HA or HA/gelatin
hydrogels (p > 0.05) and that 0.5% RGD-alginate, but not 1%
RGD-alginate hydrogel, significantly increased pigmented RPE
formation (p < 0.05). Visually this is clearly evident for hESCs
and hiPSCs at both day 30 and 45. Furthermore, flow cytometric
analysis (Fig. 5c) showed that at day 45 0.5% RGD-alginate
alone significantly increased the percentage of RPE cells as
revealed by staining with anti-CRALBP, a marker of definitive
RPE (p < 0.05).
3.5. Neural retinal formation was similar across all conditions
Quantitative assessment of retinal structures (Fig. 3) implied
that, in addition to RPE, the formation of neural retina was alsoenhanced by encapsulation in the 1% RGD-alginate hydrogel. In
an attempt to validate this finding the expression of various neural
retinal markers were measured by qRT-PCR (Fig. 6).
The qRT-PCR analysis showed that the expression of VSX2
(CHX10), a marker of neural retinal progenitor cells, was unaffected
by hydrogels compared with controls (p < 0.05). This indicated that
the number of progenitors was not significantly affected by culture
of cells in any hydrogel, compared with control conditions (Fig. 6).
The overall expression of VSX2 was, however, significantly
increased in hiPSC-derived tissue compared with that of hESCs
(p < 0.05) with the fold change being around 10 times higher at
both day 30 and day 45. This correlated with the increased number
of VSX2 positive cells in hiPSC derived retinae when compared to
hESC as detected by flow cytometric analysis at day 45 (Fig. 7a,
p < 0.05). Flow cytometric analysis of VSX2 expression also con-
firmed that the number of retinal progenitor cells was not signifi-
cantly affected by any of the hydrogels at day 45 compared with
controls (Fig 7a, p > 0.05).
Retinal ganglion cells are the first cells to mature in the normal
retina, and to measure emergence of retinal ganglion cells in cul-
ture, the expression of MATH5 was assessed by qRT-PCR in both
hESC- and hiPSC-derived EBs (Fig 6).MATH5was found to be signif-
icantly increased in 0.5% RGD-alginate cultures compared with
controls (p < 0.05), while other hydrogels had no significant effect
(p > 0.05). The increased numbers of retinal ganglion cells was also
confirmed by flow cytometric analysis of RBPMS (a selective mar-
ker of retinal ganglion cells in the mammalian retina)-positive cells
in the hiPSC-derived EBs (Suppl. Fig. 3).
Following the emergence of retinal ganglion cells, the emer-
gence of other retinal neurons was expected, in accordance with
the order of human retinal histogenesis (Fig. 1b). To assess whether
the emergence of other retinal phenotypes was affected by culture
in the hydrogels compared with controls, qRT-PCR was used to
compare the expression of PROX1 (horizontal cells), AP2a (ama-
crine cells) and CRX and RCVRN (photoreceptor progenitors)
(Fig. 6). The expression of all of these genes was unaffected by
any of the hydrogels compared with controls (p > 0.05), indicating
that enhanced RPE formation in neural retina, as indicated in Fig. 4
and 5, was not at the expense of neural retinal development. Inter-
estingly, the expression of CRX and RCVRN (p < 0.05) was signifi-
cantly increased in hiPSC- versus hESC-derived tissue,
corroborating the findings above indicating increased VSX2 expres-
sion (Fig. 1a).
IHC was performed on sections of EBs from both hESCs and
hiPSCs sampled on days 30 and 45 under all conditions (hydro-
gels and controls) to confirm the presence multiple retinal phe-
notypes as indicated by qRT-PCR and flow cytometric analysis
(Fig. 6, 7a and Supp. Fig. 3). Representative examples of develop-
ing laminated retina are shown in Fig. 7b. The IHC revealed that
laminated retina could form under all experimental conditions,
as indicated by the presence of HuC/D on the basal layer (towards
the centre of the EB) which is expressed by developing retinal
ganglion cells and amacrine cells of the inner neural retina, and
large numbers of VSX2-positive neural retinal progenitor cells
throughout the outer (apical) region of the OVs. Furthermore, a
basement membrane-like structure which was rich in collagen-
IV (COL-IV) formed along the basal surface of OVs, reminiscent
of an inner limiting membrane (ILM) of native retina. The emer-
gence of photoreceptors under all conditions was suggested by
the presence of RCVRN positive cells, outlining typical elongated
photoreceptor morphology. RCVRN is also a marker of cone bipo-
lar cells, but since these cells arise much later than cone photore-
ceptors, we expect the cells labelled were photoreceptor
precursors.
Fig. 4. Quantification of RPE-specific gene expression. Expression of MITF1, TYR and RPE65 at days 30 and 45 in hESC- and hiPSC-derived EBs as determined by qRT-PCR.
GAPDHwas used as the housekeeping gene. All samples were normalized to adult human RPE. No significant differences were seen inMITF1 expression levels (p > 0.05) across
conditions, however the expression of TYR and RPE65 were significantly increased in EBs differentiated within 0.5% RGD-alginate (p < 0.05). 1% RGD-alginate, HA and HA/
gelatin had no effect on RPE gene expression (p > 0.05). This suggested that RPE differentiation was enhanced by 0.5% alginate.
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Overall the results of this study demonstrate that the 0.5% RGD-
alginate scaffold enhanced the initial generation of 3D-derived
retinal tissue containing RPE from hESCs and hiPSCs. This is the
first study to the best of the authors’ knowledge which has shown
that 3D culture with a biomaterial scaffold can improve the gener-
ation of retinal tissue from hESC and hiPSC. Firstly, 0.5% RGD-
alginate hydrogel enhanced the development of RPE, as shown
by increased occurrence of pigmented RPE foci occupying a larger
area; increased expression of RPE markers (RPE65, TYR); and
increased percentage of CRALBP-positive cells. Furthermore, the
emergence of OVs and RPE occurring simultaneously within the
same EB was significantly increased in 0.5% RGD-alginate hydro-
gels. qRT-PCR analysis for multiple markers of neural retinal cells
(VSX2, AP2a, PROX1, CRX, RCVRN), along with flow cytometric anal-
ysis of VSX2 suggested that RPE was not being preferentially gener-
ated at the expense of neural retina, with no significant effects of
the 0.5% RGD-alginate on the expression of these markers. This
supported the finding that the total number of OVs generated
was unaffected by 0.5% RGD-alginate hydrogel, compared with
the control. Additionally, qRT-PCR analysis of MATH5 expression
levels suggested that the generation of retinal ganglion cells was
enhanced in 0.5% RGD-alginate hydrogels compared with controls.
Since retinal ganglion cells are the first cells to arise in the nativehuman retina this may suggest that the maturation of the neural
retina is accelerated by culturing EBs in 0.5% RGD-alginate hydro-
gels compared with suspension culture in media alone. Longer
term cultures are necessary to confirm whether later stages of reti-
nal development can also be enhanced using 0.5% RGD-alginate
scaffolds.
The number of EBs containing phase bright OV-like regions
occurring with our without RPE was also significantly increased
by culture in 1% RGD-alginate, however no other significant
improvements were observed. This suggested that although RGD-
alginate hydrogels in general may enhance retinal differentiation,
the concentration of the RGD-alginate scaffold is important for
optimum results. No significant improvements in any of the mea-
sures of retinal differentiation were seen for HA or HA/gelatin scaf-
folds showing that the derivation of retinal tissue was not
improved by these scaffolds. Interestingly, according to many mea-
sures, the hiPSCs showed increased generation of retinal deriva-
tives compared with hESCs, including: increased numbers of
VSX2-expressing retinal progenitor cells; increased expression of
photoreceptor markers; increased number OVs; and increased
expression of the mature RPE marker, RPE65. This is not surprising
since differences between different human pluripotent cell lines
have previously been reported [60] [61], along with differences
in their propensity to generate both retinal [62–65] and other cells
and tissues [66,67].
Fig. 5. The area occupied by pigmented RPE in scanned images of differentiating EBs and the number of CRALBP-positive cells were increased by encapsulation in 0.5% RGD-
alginate. a) Example showing how a scanned image (left) was thresholded to allow for quantification of the observable pigmented area (right). (Scale bar = 5 cm). b) Graphs
showing the% of the area taken up by EBs which was occupied by pigmented RPE in EBs derived from hESCs and hiPSCs. The % area of pigmented RPE was significantly
increased by 0.5% RGD-alginate compared with control conditions (p < 0.05). Results across both sample day and cell type were comparable (p > 0.05). c) The percentage of
cells expressing CRALBP as determined by flow cytometry at day 45 in hESC- (left) and hiPSC-derived (right) EBs. The number of CRALBP positive cells (expressed by RPE cells)
in differentiating cultures was significantly increased by 0.5% RGD-alginate only (p < 0.05). This demonstrated that there was more RPE in 0.5% RGD-alginate-encapsulated
EBs compared with controls, and supports the qRT-PCR analysis shown in Fig. 5.
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retinal differentiation and it is for this reason that in the present
study a single method of EB generation was used, namely the 96-
well plate method, which have been utilised in several other stud-
ies [22,68–70]. This allowed for the effect of hydrogel scaffolds to
be assessed with homogenously sized EBs which could be grown
in large quantities with ease, enabling quantitative assessment of
various measures of retinal ontogenesis. Notwithstanding this,
the impact of 0.5% RGD-alginate on retinal differentiation was also
observed when EBs were prepared using other methods (data not
shown). Comparison of the use of 0.5% RGD-alginate and serum-
free media to generate retinal tissue with other published results
is challenging since the efficacy of different methods is sometimes
difficult to determine and this is further compounded by the com-
plexity and variability of methods used to induce differentiation
[12,71–74]. Often the expression of differentiation markers in the
engineered tissue is not compared with native tissue, and is
instead compared with the immortalised human RPE cell line,
ARPE19, which is an imperfect alternative with several key differ-ences compared with native RPE, including: a lack of pigment RPE;
rapid proliferation; elongated cell shape; differential secretion of
growth factors and differentiation markers [75–78]. It is for this
reason that all qRT-PCR analysis in this study was normalized to
primary human RPE or retina.
Previous work [53–55] has shown that alginate hydrogel sup-
ports the maintenance of a normal pigmented RPE phenotype,
and reverses the de-differentiation that is normally seen upon
in vitro culture. The present study has also shown that RGD-
alginate hydrogels support pigmented RPE formation from
pluripotent stem cells. For clinical application to restore RPE
monolayer defects, RPE generated in EBs could be micro-
dissected from EBs, enzymatically dissociated and seeded onto a
scaffold for transplantation or injected in suspension, for example
as performed in recent clinical trials [16]. Indeed, RPE cells iso-
lated from the EBs generated in 0.5% RGD-alginate at 60 days pla-
ted onto Matrigel coated 24-well inserts of 30mm2 area formed a
deeply pigmented monolayer with typical RPE morphology
(Suppl. Fig 4).
Fig. 6. The formation of neural retina is not adversely affected by hydrogel encapsulation. qRT-PCR analysis of neural retinal differentiation markers at days 30 and day 45 in
hESC- and hiPSC-derived cultures as follows; VSX2 (retinal progenitor cells); MATH5 (retinal ganglion cells and their precursors); AP2a (amacrine cells and their precursors);
PROX1 (horizontal, amacrine and bipolar cell precursors and mature horizontal cells); CRX and RECOVERIN (photoreceptors and their precursors). 0.5% RGD-alginate increased
the expression of the RGC marker, MATH5 (p < 0.05). No other significant differences were observed between hydrogels and control conditions. This demonstrated that
hydrogel encapsulation did not adversely affect formation and development of the neural retina, and may accelerate retinal ganglion cell production.
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with RPE cells, which was observed in 0.5% RGD-alginate, may be
due to the secretion of factors by RPE, such as pigment
epithelium-derived factor (PEDF) by the RPE cells. RPE cells providethe majority of the PEDF which accumulates in the neural retina
and has been proposed to be important for retinal ganglion cell
development, regeneration and survival. Since retinal ganglion
cells are the first neural retinal cells to arise [79], prolonged culture
Fig. 7. The number of neural retinal progenitor cells was increased in 0.5% alginate hydrogel encapsulation. a) Flow cytometric analysis of VSX2-expressing cells at day 45 in
hESC- and hiPSC-derived EBs was performed to compare the number of retinal progenitor cells under each condition. Encapsulation of EBs in different hydrogels had no
significant effect on the number VSX2-positive cells (p > 0.05). This demonstrated that hydrogel encapsulation did not adversely affect retinal progenitor cell numbers, and
confirmed the qRT-PCR analysis of VSX2 expression shown in Fig. 7. b) Representative examples of IHC staining for VSX2 (retinal progenitor cells), HuCD (developing retinal
ganglion cells and amacrine cells), RCVRN (photoreceptors and their precursors), and COL-IV at day 45. Similar staining was observed in all samples on days 30 and 45 and
indicated that laminated neural retina was forming, as indicated by the qRT-PCR analysis shown in Fig. 7.
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ral retinal cells, including photoreceptors, the development of
which are also supported by the RPE [80–84], and further matura-
tion of the laminated neural retina is also enhanced.
The mechanism by which the scaffold enhances retinal tissue
formation is unclear. It was apparent from rheological characteri-
sation that the mechanical properties are very different between
the 0.5% RGD-alginate and the other three scaffolds, and the
mechanical properties of the scaffold may, as has been shown with
many other cells and tissues [67,85–91,43,92] play an important
role in retinal differentiation. It is suggested that biomaterials with
similar mechanical properties to the host tissue of interest can
enhance differentiation towards the target lineages [67,89]. This
occurs via mechano-transduction involving YAP/TAZ-mediated
Hippo pathway signalling which ultimately leads to changes in
the cytoskeleton, cell mechanics and chromatin condensation
[86,93–95]. Limited data exist on the mechanical properties of
retina [96–98], largely due to the fragility of the tissue and the lim-
ited thickness (approximated 0.25 mm) which makes such charac-
terisation challenging. However, the elastic modulus of 0.5% RGD-
alginate used in this study was found to be approximately 2 kPa,
which is within the reported range of native mammalian retina,
while the elastic modulus of 1% RGD-alginate, HA and HA/gelatin
lay outside of the reported range [99]. This may, therefore, explain
the most enhancing effects observed from EB encapsulation in 0.5%
RGD-alginate hydrogel.Additionally, cell-matrix (scaffold) binding, and therefore
downstream signalling cascades resulting in differential cell beha-
viour [100–102], including cell differentiation [87], will also likely
be markedly different between hydrogels. Cell-scaffold adhesion is
mediated through the RGD motifs in RGD-alginate scaffolds (with
the density being halved in 0.5% versus 1% RGD-alginate), which
is bound by all five aV integrins, two b1 integrins (a5, a8) and
aIIbb3 [102]. In contrast, HA-binding is mediated by CD44 [103],
CD168 (also known as RHAMM or HMMR) and layilin [104,105],
while gelatin is proposed to be bound predominantly by the man-
nose receptor family [106] as well as RGD binding integrins
[107,108].
Moreover, in the different hydrogels studied differential diffu-
sion and accumulation of key proteins, including growth factors
and ECM components, such as collagens, may occur [109,110]. This
is likely due to the differences; in the net charge of the HA, gelatin,
and RGD-alginate scaffolds; the apparent differences in pore sizes
and interconnectivity [111]; and the differential presence of pro-
tein binding domain ligands, such as to the HA-binding domain
in proteoglycans [112]. The differential accumulation of cell-
synthesised ECM, the ultimate ECM-binding by the cells, and pos-
sible further differential accumulation of growth factors, will likely
also influence differentiation [113,114]. Moreover, differences in
the 3D surface topology of scaffolds have previously been reported
to influence the differentiation of cells derived from hESCs [115]
which may suggest the differences in pore wall smoothness and
N.C. Hunt et al. / Acta Biomaterialia 49 (2017) 329–343 341pore sizes observed between scaffolds in this study may have influ-
enced cell differentiation.
The present study may suggest that the use of RGD-alginate
hydrogel is preferential to the HA-based hydrogels, which are cur-
rently being investigated for the delivery of retinal cells [44,49].
Furthermore, it provides a new approach for the enhanced genera-
tion of viable 3D laminated neural retina with simultaneous
appearance of RPE foci which can be of useful significance for the
derivation, transport and transplantation of this tissue into the
compromised retina.
5. Conclusions
In this study it has been demonstrated that the derivation of
RPE alone and in conjunction with neural retina from hESCs and
hiPSCs is enhanced by culture in an RGD-alginate hydrogel scaf-
fold. Further work should assess whether over a longer culture per-
iod the maturation of retinal tissue is enhanced, or whether
additional optimisation of EB generation, in conjunction with this
scaffold, can further improve retinal generation. Further work
should seek to understand the mechanism of RGD-alginate
scaffold-enhanced retinal ontogenesis. The findings may suggest
that RGD-alginate could be preferential to HA-based hydrogels
for in vivo delivery of retinal cells and this work may have implica-
tions for the derivation of other pigmented, neural or epithelial
tissue.
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